Jennifer E Thorne Selected Research

Opportunistic Infections (Opportunistic Infection)

4/2015	Incidence and long-term outcomes of the human immunodefıciency virus neuroretinal disorder in patients with AIDS.
2/2013	Non-cytomegalovirus ocular opportunistic infections in patients with acquired immunodeficiency syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jennifer E Thorne Research Topics

Disease

48	Uveitis 01/2023 - 08/2005
34	Inflammation (Inflammations) 10/2023 - 08/2005
22	Acquired Immunodeficiency Syndrome (AIDS) 10/2022 - 05/2003
21	Panuveitis 01/2023 - 12/2006
15	Cataract (Cataracts) 04/2024 - 08/2006
13	Macular Edema 04/2024 - 09/2011
13	Scleritis (Episcleritis) 01/2022 - 12/2002
12	Retinitis 07/2017 - 05/2003
10	Bullous Pemphigoid (Pemphigoid) 01/2021 - 01/2004
9	Intermediate Uveitis (Chronic Cyclitis) 01/2021 - 10/2009
9	Cytomegalovirus Retinitis 06/2012 - 05/2003
7	Anterior Uveitis 01/2022 - 11/2009
7	Infections 01/2021 - 12/2008
7	Retinal Detachment (Retinal Detachments) 01/2019 - 12/2004
6	Posterior Uveitis 04/2022 - 03/2010
6	Neoplasms (Cancer) 01/2022 - 12/2008
5	Glaucoma 01/2022 - 08/2013
5	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2022 - 05/2007
5	Hypertension (High Blood Pressure) 01/2019 - 10/2015
5	Eye Diseases (Eye Disease) 11/2012 - 08/2005
4	Band-Shaped Corneal Dystrophy 01/2022 - 09/2008
4	Birdshot Chorioretinopathy 01/2022 - 07/2005
3	Hepatitis 01/2021 - 10/2003
3	Vitreous Hemorrhage 01/2019 - 05/2009
2	Hyperglycemia 01/2023 - 08/2012
2	Anemia 01/2023 - 12/2008
2	Granuloma 05/2022 - 12/2009
2	Edema (Dropsy) 01/2022 - 12/2016
2	Necrosis 01/2022 - 07/2009
2	Atrophy 04/2021 - 12/2016
2	COVID-19 01/2021 - 01/2021
2	Macular Degeneration (Age-Related Maculopathy) 01/2019 - 09/2007
2	Retinal Vein Occlusion 01/2017 - 04/2015
2	Epiretinal Membrane (Epiretinal Membranes) 01/2017 - 05/2007
2	Obesity 10/2016 - 01/2016
2	Overweight 10/2016 - 01/2016
2	Opportunistic Infections (Opportunistic Infection) 04/2015 - 02/2013
2	Optic Nerve Diseases (Optic Neuropathy) 08/2013 - 04/2007
2	Choroidal Neovascularization 09/2007 - 12/2006
2	Conjunctivitis 09/2006 - 08/2003
1	Sudden Infant Death (SID) 12/2023
1	Tremor (Tremors) 01/2023
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Ocular Hypertension (Glaucoma, Suspect) 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2021

Drug/Important Bio-Agent (IBA)

52	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2024 - 12/2002
20	Prednisone (Sone)FDA LinkGeneric 01/2023 - 06/2003
14	SteroidsIBA 12/2020 - 10/2011
11	Fluocinolone Acetonide (Capex)FDA LinkGeneric 04/2024 - 10/2011
11	Retinaldehyde (Retinal)IBA 04/2021 - 12/2002
9	Immunosuppressive Agents (Immunosuppressants)IBA 12/2023 - 10/2008
6	Dexamethasone (Maxidex)FDA LinkGeneric 04/2024 - 01/2015
6	RNA (Ribonucleic Acid)IBA 01/2022 - 04/2015
6	Mycophenolic Acid (Cellcept)FDA LinkGeneric 03/2010 - 12/2002
5	Methotrexate (Mexate)FDA LinkGeneric 01/2023 - 10/2008
5	Adalimumab (Humira)FDA Link 11/2021 - 09/2016
5	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 01/2004
5	AntimetabolitesIBA 01/2016 - 10/2008
4	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 04/2024 - 09/2011
4	Fluorescein (Funduscein)FDA LinkGeneric 04/2024 - 09/2007
4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2021 - 07/2004
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2010 - 12/2008
4	Azathioprine (Imuran)FDA LinkGeneric 10/2009 - 10/2008
3	Triamcinolone (Aristocort)FDA Link 01/2019 - 09/2007
3	Alkylating AgentsIBA 12/2013 - 12/2008
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2010 - 08/2003
2	prednisolone acetate FDA LinkGeneric 10/2023 - 09/2008
2	Hemoglobins (Hemoglobin)IBA 01/2023 - 10/2005
2	CholesterolIBA 01/2019 - 10/2015
2	GlucocorticoidsIBA 09/2016 - 11/2007
2	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2014 - 02/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2013 - 12/2008
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 12/2009 - 03/2004
2	AutoantibodiesIBA 07/2008 - 01/2004
1	Ranibizumab (Lucentis)FDA Link 01/2023
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	difluprednate FDA Link 01/2022
1	Hepatitis B e AntigensIBA 01/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	Surface Antigens (Surface Antigen)IBA 01/2021
1	SolutionsIBA 01/2019

Therapy/Procedure

47	Therapeutics 04/2024 - 06/2003
14	Highly Active Antiretroviral Therapy (HAART) 01/2021 - 05/2003
8	Art Therapy 01/2023 - 01/2013
6	Injections 04/2024 - 09/2011
6	Drug Therapy (Chemotherapy) 02/2023 - 06/2003
5	Vitrectomy 01/2017 - 11/2012
3	Intraocular Injections 04/2024 - 08/2013
3	Aftercare (After-Treatment) 04/2012 - 09/2008
2	Trabeculectomy (Trabeculoplasty) 01/2022 - 01/2022
2	Lasers (Laser) 01/2022 - 01/2017
2	Immunomodulation 01/2021 - 08/2016
2	Biological Therapy 04/2017 - 07/2008
2	Tattooing 11/2015 - 09/2014
1	Penetrating Keratoplasty 05/2022
1	Transplantation 01/2022